The National Institutes of Health, more typically called NIH, is a government agency operating in the United States Department of Health and Human Services that is basically accountable for ensuring and supporting all the nation's biomedical and health-related research studies.
The grants and programs of the NIH are all designed to contribute to the realization of its overall agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that information to improve health, lengthen life, and cut back the burdens of sickness and disability."
In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they intend to create a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NINDS.
The NIH and NINDS have stipulated that the trials and research studies that will be funded under this programme are those that are concentrating on products that are associated to the goals and missions of the NINDS, such as an analysis of drugs, biologics, devices, or diagnostics, and even surgical, behaviour or rehabilitation treatments.
Fundamentally, the Exploratory Clinical Trials for Small Business Grant Program has been established to help diminish or eradicate the burden that's experienced by people who are afflicted with neurological defects.
Having said that , the NINDS attempts to provide support to small businesses in their quest to develop developing technologies that may probably be useful to the objective in focus.
The examples of the types of studies that will be supported under this program are the ones that aim to:
a) Evaluate and optimize the dose, formulation, safety, tolerability/pharmacokinetics of a certain intervention or diagnostic test in healthy volunteers or the target population
b) Potential clinical verification of a diagnosis
c) Asses whether or not an intervention produces sufficient evidence of short-term activity in a human "proof of concept" trial
d) Determine the best of several potential interventions or dosing programmes that will be evaluated in a successive trial, primarily based on tolerability, biological activity, or preliminary clinical efficacy.
The NIH and NINDS are ready to administer a funding amount of $750,000 per grant awardee to support the execution of this programme.
The institutions and organizations who will be considered able to submit an application under this programme are those Small Business Concerns that meet the following criteria:
a) SBCs that are generally organized for profit and is found and operating in the United States, and makes a substantial contribution to the U. S. economy through payment of taxes or use of American products, materials or labor;
b) SBCs that are in the legal form of an individual proprietorship, partnership, limited liability firm, enterprise, collaboration, organisation, trust or cooperative;
c) SBCs that do not have more than 500 workers
d) SBSs that are at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States.
The grants and programs of the NIH are all designed to contribute to the realization of its overall agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that information to improve health, lengthen life, and cut back the burdens of sickness and disability."
In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they intend to create a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NINDS.
The NIH and NINDS have stipulated that the trials and research studies that will be funded under this programme are those that are concentrating on products that are associated to the goals and missions of the NINDS, such as an analysis of drugs, biologics, devices, or diagnostics, and even surgical, behaviour or rehabilitation treatments.
Fundamentally, the Exploratory Clinical Trials for Small Business Grant Program has been established to help diminish or eradicate the burden that's experienced by people who are afflicted with neurological defects.
Having said that , the NINDS attempts to provide support to small businesses in their quest to develop developing technologies that may probably be useful to the objective in focus.
The examples of the types of studies that will be supported under this program are the ones that aim to:
a) Evaluate and optimize the dose, formulation, safety, tolerability/pharmacokinetics of a certain intervention or diagnostic test in healthy volunteers or the target population
b) Potential clinical verification of a diagnosis
c) Asses whether or not an intervention produces sufficient evidence of short-term activity in a human "proof of concept" trial
d) Determine the best of several potential interventions or dosing programmes that will be evaluated in a successive trial, primarily based on tolerability, biological activity, or preliminary clinical efficacy.
The NIH and NINDS are ready to administer a funding amount of $750,000 per grant awardee to support the execution of this programme.
The institutions and organizations who will be considered able to submit an application under this programme are those Small Business Concerns that meet the following criteria:
a) SBCs that are generally organized for profit and is found and operating in the United States, and makes a substantial contribution to the U. S. economy through payment of taxes or use of American products, materials or labor;
b) SBCs that are in the legal form of an individual proprietorship, partnership, limited liability firm, enterprise, collaboration, organisation, trust or cooperative;
c) SBCs that do not have more than 500 workers
d) SBSs that are at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States.
About the Author:
Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.
She also maintains Websites providing resources on environmental grants and grants for youth programs.
She also maintains Websites providing resources on environmental grants and grants for youth programs.
No comments:
Post a Comment